Long-term outcome and quality of life after biological aortic valve replacement in non-elderly adults.

CONCLUSIONS: Biological AVR in ≤ 60 years old patients is associated with a significant occurrence of actual AV re-intervention and MACCE at 10 to 12 years. Mental QoL after biological AVR was superior compared to healthy controls. The effect of the most recently developed bioprosthesis, specifically for younger patients, needs to be evaluated. Therefore, a shared decision -making process in prosthetic aortic valve selection is mandatory in AVR patients ≤ 60 years. PMID: 32526161 [PubMed - as supplied by publisher]
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Ann Thorac Surg Source Type: research